Drug Shortage Report for ROCURONIUM BROMIDE INJECTION
Report ID | 240927 |
Drug Identification Number | 02528657 |
Brand name | ROCURONIUM BROMIDE INJECTION |
Common or Proper name | ROCURONIUM BROMIDE INJECTION |
Company Name | EUGIA PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ROCURONIUM BROMIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | Vial |
ATC code | M03AC |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-09-15 |
Estimated end date | 2025-03-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-12-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-12-23 | French | Compare |
v3 | 2024-12-23 | English | Compare |
v2 | 2024-10-23 | French | Compare |
v1 | 2024-10-23 | English | Compare |
Showing 1 to 4 of 4